Physician profile
Bassel Alkhalil
NPI 1790967834
$3,528.59
in general payments reported to CMS, 2019-2025
22 companies · $62.32 in 2025
The $62.32 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $593 · 2020: $334 · 2021: $366 · 2022: $1,358 · 2023: $189 · 2024: $626 · 2025: $62.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $466 · Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $465.70 |
| Food and Beverage | $412.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,631.93 | 2019-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $667.91 | 2022-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $365.55 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $205.84 | 2019-2024 | Lifevest |
| Janssen Pharmaceuticals, INC | $92.47 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $88.41 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $69.85 | 2019-2020 | |
| Akcea Therapeutics, INC. | $49.56 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $47.20 | 2019 | |
| Teleflex LLC | $42.85 | 2022-2023 | Guideliner |
| Medtronic, INC. | $37.28 | 2022-2023 | Cobalt Dr Mri Surescan |
| Amgen INC. | $35.32 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.16 | 2022-2025 | Capvaxive, Verquvo |
| Pfizer INC. | $28.15 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $21.51 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $19.73 | 2023 | Lifesparc |
| Amarin Pharma, INC. | $18.61 | 2019 | |
| Alnylam Pharmaceuticals INC. | $17.33 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.97 | 2022 | |
| Getinge USA Sales, LLC | $14.51 | 2025 | Cardiohelp |
| Vital Connect, INC | $13.84 | 2025 | Vitalpatch Rtm |
| Chiesi USA, INC. | $13.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassel Alkhalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.